Physiologically based pharmacokinetic modeling is well established in the pharmaceutical industry and is accepted by regulatory agencies for the prediction of drug–drug interactions. However, physiologically based pharmacokinetic modeling is valuable to address a much wider range of pharmaceutical applications, and new regulatory impact is expected as its full power is leveraged. As one example, PBPK is already routinely used during drug discovery for in-vitro to in-vivo translation and pharmacokinetic modeling in preclinical species, and this leads to the application of verified models for first-in-human pharmacokinetic predictions.

This week’s available presentation is titled “Combining In-Vivo Animal Models with Physiologically Based Pharmacokinetics (PBPK) Modeling to Optimize Oral Formulation Dosage Forms” from Handan He / Tycho Haimbach at Novartis. This presentation overviews applications of PBPK absorption modeling tools. It also examines case examples of prediction on PPI effects, formulation dependent PBPK, food food effect predictions, comparison of IVIVC vs PBIVIVC and biorelevant permeability challenges, as well as overall recommendations.

 

 

Need Access to More While Working Remotely? Check out Curtis & Coulter’s Virtual Drug Product Development Content Toolkit

While you are working remotely, we can help you keep up-to-date with the advancing drug product development landscape, by providing you and your team access to innovative drug development strategies and approaches from the comfort of working from home. Stay in the know and relevent with 3 year’s worth (115+) leading industry presentations and case studies from our popular:

 

  • Controlled & Modified Drug Release Summits
  • Peptide Drug Design & Delivery Summits
  • Global Drug Bioavailability Enhancement Summits

Additionally, open the door to connecting digitally with our previous drug product development participants and innovators instantly, as well as explore opportunities to share your digital content and technology to our wider audience. Whether you are a pharma/biotech company looking for new relevant drug product development content, or a consultant/solution provider looking to network we have a digital remote working solution for you! Click below to find out more.

Pin It on Pinterest

Share This

Share this with a friend or colleague!